Global Adoption of CH4 Vaccine by End of 2026 | Categorical | | | 7 months ago | |
CH4 Vaccine Trial Phase Completion by End of 2024 | Binary | | | 7 months ago | |
Additional Funding Secured for CH4 Vaccine Post-Initial Success | Binary | | | 7 months ago | |
Expansion of ArkeabioTM's technology applications by 2025 | Categorical | | | 8 months ago | |
ArkeabioTM vaccine regulatory approval by end of 2024? | Binary | | | 8 months ago | |
Additional funding for ArkeabioTM by end of 2025? | Binary | | | 8 months ago | |
Methane Reduction Levels Achieved by CH4 Vaccine in First Year | Categorical | | | 7 months ago | |
Impact of CH4 Vaccine on Global Livestock Methane Emissions by 2026 | Categorical | | | 7 months ago | |
Global adoption level of ArkeabioTM vaccine by 2025 | Categorical | | | 8 months ago | |
Methane reduction percentage by ArkeabioTM's vaccine by end of 2025 | Categorical | | | 8 months ago | |
Over 30% Methane Reduction Achieved in Initial CH4 Vaccine Tests by Mid-2025 | Binary | | | 7 months ago | |
Successful methane reduction in trial within 6 months? | Binary | | | 8 months ago | |
